Albumin-conjugated drug is irresistible by single gene mutation of endocytic system: Verification by genome-wide CRISPR-Cas9 loss-of-function screens

Published 2020 View Full Article

Authors

Keywords

Drug resistance, Albumin-conjugated drug, CRISPR-Cas9 screen, Triptolide, Pancreatic cancer

Journal

JOURNAL OF CONTROLLED RELEASE

Volume 323, Issue -, Pages 311-320

Publisher

Elsevier BV

Online

2020-04-24

DOI

10.1016/j.jconrel.2020.04.035

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.